| 1. Blood donor iron deficiency: status and management |
Page:1—4 |
| 2. Ferritin in whole blood donors: an investigation in Beijing |
Page:4—7 |
| 3. Investigation and analysis of plasma ferritin levels in plateletpheresis donors |
Page:8—12 |
| 4. Hemoglobin and ferritin status in frequent plateletpheresis donors |
Page:12—15 |
| 5. The ferric metabolism of male regular plateletpheresis donors with plasma ferritin < 30 μg/L |
Page:15—19 |
| 6. Correlation between adhesion molecules on the surface of red blood cell membrane and red blood cell lifespan |
Page:19—22 |
| 7. Nucleic acid technology(NAT) testing for blood screening: A comparative study on individual donation and minipool NAT test |
Page:22—26 |
| 8. Parameters optimization in Heparin affinity chromatography purification of human coagulation factor Ⅸ |
Page:26—29 |
| 9. Perioperative blood transfusionfor patients undergoing totalhysterectomy |
Page:29—31 |
| 10. Correlation analysis of platelet antibody between adverse pregnancy and the number of pregnancies |
Page:32—34 |
| 11. Influencing factors of platelet antibody screening in pregnant women |
Page:34—36 |
| 12. Crossmatch incompatibility caused by anti-I antibody: 38 cases, containing 1 rare case of adult i blood group producing anti-I |
Page:36—39 |
| 13. Blood type incompatibility caused by cold agglutination: A study of 16 cases |
Page:40—43 |
| 14. Effect of adequate amount of tranexamic acid before operation on blood loss and safety in posterior lumbar fusion with multiple segments |
Page:43—47 |
| 15. Clinical blood use in Tibet Autonomous Region People′s Hospital: A respective study of 2014~2018 |
Page:48—52 |
| 16. Antigen profile and antibody frequency of Wra in voluntary blood donors in Shaanxi province, containing 2 clinical cases of anti-Wra identification |
Page:52—54 |
| 17. HBV infection in voluntary blood donors in Qingdao, China: Serological and viral characterizations |
Page:55—59 |
| 18. Fluctuation of peripheral blood levelamongapheresis platelet donors aged 56~60 in Guangzhou |
Page:59—62 |
| 19. Hepatitis E virus seroprevalence among blood donors in Liuzhou, China |
Page:62—64 |
| 20. Whole blood collection at street fixed blood donation sites in Chengdu |
Page:65—67 |
| 21. HIV-, HBV- and HCV- NAT yield in individual donations: a multi-center analysis in Henan province from 2017 to 2019 |
Page:68—72 |
| 22. Factors related to off-site vasovagal reaction in whole blood donors |
Page:72—74 |
| 23. The grey area of HBsAg enzyme-linked immunosorbent assay (ELISA) in blood screening laboratory |
Page:74—77 |
| 24. Information sharing system for donation interval query in Yangtze River Delta |
Page:77—79 |
| 25. Information system of electronic blood-donation certificate in Zhejiang province |
Page:80—82 |
| 26. Blood inventory early warning system: the application in inventory management |
Page:83—84 |
| 27. Diagnosis and treatment of delayed hemolytic transfusion reaction: A case study |
Page:85—88 |
| 28. Multiple myeloma patients treated with anti-CD38 monoclonal antibody Daratumumab producing anti-Leb1: A case study |
Page:88—90 |
| 29. Practices in British blood services: A comparatve study with Chinese status |
Page:91—94 |
| 30. Recentdevelopment and enlightenment ofblood service in Japan |
Page:95—98 |
| 31. Analysis on pre-donation blood testing in blood services in Chongqing |
Page:1279—1281 |
| 32. Analysis on the current monitoring and management of blood donation adverse reaction in Chongqing |
Page:1282—1285 |
| 33. Blood donation recruitment and effect evaluation of blood services in Chongqing |
Page:1286—1289 |
| 34. Serological characteristics and genotype analysis of D epitope blood group of RhD variant individuals in Guangzhou |
Page:1290—1295 |
| 35. β-lactam antibiotics detection using microcolumn gel technology |
Page:1296—1299 |
| 36. Application of traditional Chinese medicine Qingkailing to extend platelet storage in vitro: the metabolism and morphology study |
Page:1299—1304 |
| 37. Study on gene polymorphism of multiple RBC blood group systems in Mongolian population in Inner Mongolia |
Page:1305—1309 |
| 38. Analysis of NAT non-reactive results implicated in HBsAg ELISA reactive blood donors by multi-assays |
Page:1310—1313 |
| 39. NAT results of HBV and HCV under different vacuum collection tubes, storage temperature and storage time |
Page:1314—1317 |
| 40. Clinicalstudy of low dose dexamethasone in preventing severe CRS after CD19 CAR-T therapy |
Page:1317—1320 |
| 41. Impact of monoclonal anti-CD47 on pre-transfusion testing and its solution |
Page:1321—1324 |
| 42. To guide the preparation of blood before liver transplantation: the establishment of multiple regression equation based on R language |
Page:1325—1328 |
| 43. Effects of tranexamic acid on intraoperative blood transfusion and postoperative thromboelastogram parameters in patients with partial hepatic resection of hydatid hepatica at high altitude |
Page:1328—1331 |
| 44. HTLV prevalence among blood donors in mainland China in recent 10 years: a meta-analysis |
Page:1332—1338 |
| 45. Solutions to cross-matching incompatibility in clinical: retrospective study of 1 770 cases in Shenzhen |
Page:1339—1342 |
| 46. Pre-transfusional screening and identification of irregular red blood cell antibody in different nationalities, Guizhou, China |
Page:1343—1347 |
| 47. Complaints of blood quality: from 2014 to 2019 in Changsha |
Page:1347—1351 |
| 48. Deferral causes of apheresis platelet donors during primary screening and the countermeasures, Qinghai |
Page:1351—1353 |
| 49. Influence of popularizing relevant knowledge on voluntary blood donation of patients′ families: in terms of knowledge, attitude and practice |
Page:1354—1356 |
| 50. Analysis of the preferences for blood donation souvenirs among blood donors, Beijing |
Page:1357—1359 |
| 51. Characteristics of elderly blood donors in Anyang city |
Page:1360—1362 |
| 52. Characteristics of blood donors under COVID-19 epidemic in Tianjin |
Page:1363—1367 |
| 53. SARS-CoV-2 seroprevalence among voluntary blood donors: A retrospective analysis in Xi′an |
Page:1367—1369 |
| 54. Study on prediction of clinical demand for plasma components in Suzhou city based on ARIMA model |
Page:1370—1373 |
| 55. HBV DNA load detected by two domestic fluorescent quantitative PCR reagents: a comparative analysis |
Page:1374—1377 |
| 56. Effect of modified blood bag catheter transfer on reducing discard rate of leukocyte-depleted blood |
Page:1377—1379 |
| 57. Quality comparison of cold cryoprecipitates in two different volumes |
Page:1379—1381 |
| 58. Application of gel adsorption tank in large-scale production of human prothrombin complex |
Page:1382—1384 |
| 59. Effects of human albumin products on human stem cell culture |
Page:1385—1387 |
| 60. Effect of platelet donation frequency on iron, cooper, and zinc content and superoxide dismutase activity |
Page:1388—1391 |
| 61. Application of Tencent collectiontable in satisfaction survey of blood donors |
Page:1391—1393 |
| 62. Identification of multiple unexpected antibodies in a pregnant woman with thalassemia, and the blood crossmatch strategy |
Page:1394—1396 |
| 63. Thrombocytopenia induced by Indobufen in an elderly patient |
Page:1397—1399 |
| 64. Differences and similarities of basic standards for blood banks between China and Russia |
Page:1400—1403 |
| 65. Research progress on thrombogenesis induced by human stem cells in vitro |
Page:1403—1408 |
| 66. Research progress of CD36 antigen deletion and transfusion-related immunity |
Page:1408—1411 |
| 67. Thoughts and explanations on the development of Standards for Basic Functions of Apheresis Plasma Information System |
Page:1412—1414 |
| 68. Mechanism of platelet activation via NF-κB signaling pathway causing human pulmonary microvascular endothelial cell injury |
Page:1177—1180 |
| 69. Hepatitis B virus infection confirmation and infection status identification in blood donors without serological markers |
Page:1181—1185 |
| 70. -D- phenotype screening by polybrene method |
Page:1186—1190 |
| 71. Evaluation of modified IAT with twoself-made low ionic-strength solutions |
Page:1190—1192 |
| 72. Molecular biologicalstudy of DEL in RhD-negative blood donors, Dalian |
Page:1193—1196 |
| 73. Prevalence of hepatitis E virus infection among blood donors |
Page:1197—1199 |
| 74. Effect of human immunoglobulin manufacturing process on polymer content |
Page:1199—1201 |
| 75. TEG evaluation and blood transfusion prediction model for patients with upper gastrointestinal bleeding |
Page:1202—1206 |
| 76. Characteristics and correlation analysis of thromboelastogram and coagulation related indexes in patients with preeclampsia |
Page:1207—1209 |
| 77. Traditional Chinese medicine combined with plasma exchange for the treatment of HDN due to maternal-fetal ABO incompatibility |
Page:1209—1212 |
| 78. Effectiveness of platelet transfusion in children receiving extracorporeal membrane oxygenation |
Page:1213—1215 |
| 79. Monoclonal anti-CD47 interference inpre-transfusion testing: clinical trials at home and abroad |
Page:1215—1218 |
| 80. Blood transfusion efficacy in patients with major and minor cross-match incompatibility: analysis of 17 cases |
Page:1218—1221 |
| 81. Construction of Blood Transfusion Departments in tertiary hospitals in Yangtze River Delta |
Page:1221—1224 |
| 82. External quality assessment of NAT blood screening: an inter laboratory analysis |
Page:1225—1227 |
| 83. Analysis of HBV serological markers of donor blood samples implicated in TMA triplex + but discriminatory test-samples |
Page:1228—1231 |
| 84. HBV infection in window period among repeated blood donors: Residual risk assessment and trend analysis |
Page:1231—1234 |
| 85. Occult hepatitis B virus load and molecular mutation in blood donors, Huzhou |
Page:1235—1237 |
| 86. Influencing factors of platelet-rich plasma collection |
Page:1238—1241 |
| 87. Causes of blood donor deferral in primary blood screening, Hangzhou |
Page:1242—1244 |
| 88. Profile of irregular antibodies among voluntary blood donors: 2018 to 2020 in Jiaxing |
Page:1245—1247 |
| 89. The effects of blood donors satisfaction survey based on computer-aided technology |
Page:1248—1252 |
| 90. Efficacy of telephone and WeChat appointment for platelet apheresis donation during COVID-19 epidemic: a comparative study in Shijiazhuang |
Page:1252—1255 |
| 91. How COVID-19 epidemic and anxiety affect the blood donation behaviors of college students |
Page:1256—1258 |
| 92. Analysis of glycosylated hemoglobin in apheresis platelet donors |
Page:1259—1260 |
| 93. Preparation of cryoprecipitate coagulation factor from liquid-state plasma by supercooling method |
Page:1261—1262 |
| 94. Preliminary application of drones in emergency blood delivery |
Page:1263—1265 |
| 95. Occupational exposure of blood bank staff: Cause analysis and risk prevention |
Page:1266—1268 |
| 96. Establishment and application of sentinel indicators of pre-analytical phase in blood screening laboratory |
Page:1269—1273 |
| 97. Sequence analysis and confirmation of new allele HLA-DQB1*03:359: a case report |
Page:1273—1275 |
| 98. Application process of therapeutic plasma exchange for neurological diseases in Blood Transfusion Department |
Page:1275—1277 |
| 99. Expert consensus of identification of antibodies to red cell antigens |
Page:1061—1065 |
| 100. Effect of HLA-G expressed in platelets on Tax protein of human T lymphocyte leukemia type 1 virus |
Page:1066—1069 |
| 101. Expression of ABO blood group antigen on platelets of blood donors |
Page:1069—1072 |
| 102. Study on the adsorption of inflammatory cytokines and blood compatibility of graphene oxide electrostatic self-assembled polyester material |
Page:1072—1078 |
| 103. Expression of B7-H6 in peripheral blood and bone marrow of patient with chronic myeloid leukemia and its clinical significance |
Page:1078—1081 |
| 104. Efficacy evaluation of a SARS-CoV-2 diagnostic reagent for total antibody detection |
Page:1082—1086 |
| 105. Concentration of growth factors in platelet rich plasma under different activators |
Page:1086—1089 |
| 106. Methodological evaluation of nephelometric assay for the determination of IgA residues in human intravenous immunoglobulin |
Page:1090—1093 |
| 107. Effect of leukocyte-depleted suspended red blood cells storaged for different time on patients with hematologic diseases and malignant tumors |
Page:1094—1098 |
| 108. Impact of preoperative anemia on perioperative blood transfusion and outcomes in patients undergoing mitral valve surgery |
Page:1098—1100 |
| 109. Effects of different hemodialysis methods on insulin resistance, inflammatory factors and coronary artery calcification in patients with non-diabetic end-stage renal disease |
Page:1101—1105 |
| 110. Clinical study of Roxastat combined with levocarnitine and polysaccharide iron complex in patients with chronic renal failure hemodialysis anemia |
Page:1106—1109 |
| 111. Correlation between Rh blood group antigen profiles in pregnant women and hemolytic disease of the newborn in Qingdao area: A retrospective study |
Page:1109—1112 |
| 112. Evaluation and comparison of thromboelastography and conventional coagulation tests for blood coagulation function in children with Kasabach-Merritt syndrome |
Page:1112—1116 |
| 113. Clinical characteristics and risk factors of adverse reactions to blood transfusion in Chinese adults based on evidence-based medicine |
Page:1117—1120 |
| 114. The impact of ceasing mutual blood donation on voluntary blood donation in Guangzhou |
Page:1121—1125 |
| 115. Why did street blood donors re-donate or lapse? A analysis in Nanjing |
Page:1126—1129 |
| 116. Implementation and application of telephone recruitment for apheresis platelet donors: based on the whole process information management of blood collection and supply |
Page:1130—1133 |
| 117. Prediction on clinical platelet demand in Suzhou based on ARIMA model |
Page:1134—1137 |
| 118. Characteristics of NAT reactive voluntary blood donors, Zhengzhou from 2018 to 2019 |
Page:1137—1140 |
| 119. How apheresis donation effects peripheral blood parameters in plateletpheresis donors: Propensity Score Matching method |
Page:1141—1144 |
| 120. Related quality indexes of different common plasma products: A comparative study |
Page:1144—1146 |
| 121. Verification of method for microbial limit test on diatomite and pearlite |
Page:1147—1149 |
| 122. Epitope analysis and molecular study of weak D type 136: A case report |
Page:1149—1152 |
| 123. Identification of a rare anti-Dib combined with multiple antibodies and clinical blood transfusion practice |
Page:1152—1155 |
| 124. Preparation and preliminary identification of specific monoclonal antibody against AB blood group antigen |
Page:1156—1159 |
| 125. Application of intelligent voice call technology in the recall of lapsed blood donors |
Page:1159—1161 |
| 126. Hemolytic disease of newborn with D antigen masking caused by anti-G combined with anti-D : a case report |
Page:1162—1164 |
| 127. Advances in platelet transcriptomics |
Page:1165—1168 |
| 128. The comparison of the managements and practices of safe administration of blood components between United Kingdom and China (Part 6) |
Page:1169—1174 |
| 129. Consent for blood transfusion: How is it understood by transfusion candidates |
Page:939—942 |
| 130. Practice of informed consent audit system for clinical transfusion in a large tertiary hospital |
Page:943—948 |
| 131. Establishment of intelligent management system of surgical blood based on closed-loop blood transfusion information management and blood bank forward system |
Page:949—951 |
| 132. Application of PDCA in the information management of blood transfusion medical records |
Page:952—955 |
| 133. Practice of reimbursement of blood expenses in hospital using information platform |
Page:955—957 |
| 134. Detection of anti-HLA and anti-MICA in convalescent plasma from individuals recovered from COVID-19 |
Page:958—960 |
| 135. Expression analysis of miRNA profiles in apheresis platelets at the end of storage under riboflavin and ultraviolet-Blight treatment |
Page:961—966 |
| 136. Treatment of platelet transfusion refractory caused by anti-HLA in pregnancy complicated with aplastic anemia |
Page:967—969 |
| 137. Allelic polymorphism of 13 rare blood group systems in Li Ethnic Group in Hainan |
Page:970—974 |
| 138. To remove monoclonal anti-CD38 interference from compatibility testing: A simple method |
Page:974—977 |
| 139. Analysis and process improvement concerning adverse events to insufficient plasma transfusion |
Page:978—982 |
| 140. Analysis of orthopedic surgical blood transfusion and study on maximum surgical blood order schedule |
Page:982—986 |
| 141. Prognostic analysis of critically ill patients with coagulation dysfunction by thrombelastogram and coagulation 4 items combined APACHEⅡ score |
Page:987—991 |
| 142. Clinical value of thromboelastogram in evaluating coagulation fuction of patients with liver cancer |
Page:992—996 |
| 143. The role of thromboelastography in diagnosis and treatment of PICC related venous thrombosis in tumor patients |
Page:997—999 |
| 144. Preparation and clinical application of 0.7~0.8 hematocrit concentrated washed red blood cells in intrauterine blood transfusion for fetal anemia |
Page:1000—1002 |
| 145. Effect of anti-platelet antibodies on the efficacy of immunoglobulin therapy and Treg/Th17 ratio in children with immune thrombocytopenia |
Page:1003—1005 |
| 146. Investigation of preoperative anemia and perioperative blood transfusion in patients with duodenal papillarycarcinoma in a tertiary hospital |
Page:1006—1009 |
| 147. Factors that contributing to the intention of blood donation: An application of the protection motivation theory |
Page:1010—1013 |
| 148. Effects on the recruitment of inactive and lapsing blood donors, Questionnaire study based on motivators and deterrents |
Page:1013—1017 |
| 149. Promote and deter factors of blood donation among street blood donors in Nanjing based on the theory of planned behavior |
Page:1017—1021 |
| 150. Influencing factors related to repeated blood donation among college students in Guangzhou |
Page:1021—1025 |
| 151. Confidential unit exclusion from 2011 to 2020, Xiamen |
Page:1026—1028 |
| 152. HIV antibody screening and confirmative tests of voluntary blood donors in a hospital in Beijing: A retrospective analysis |
Page:1029—1031 |
| 153. Performance verification of four nucleic acid detection systems: A comparitve study |
Page:1032—1035 |
| 154. Study on performance verification of enzyme-linked immunosorbent assay in blood screening laboratory |
Page:1036—1039 |
| 155. Nursing care of TRALI in one multiple trauma patient caused by blood transfusion, case report |
Page:1040—1041 |
| 156. Advances in the anti-ageing effects of GDF11 in blood |
Page:1041—1046 |
| 157. Research progress on the correlation between blood donor factors and red blood cell storage lesion |
Page:1046—1049 |
| 158. Function of platelet-derived extracellular vesicles in adverse reactions to blood transfusion |
Page:1050—1054 |
| 159. Research progresses in donation related vasovagal reaction |
Page:1055—1060 |
| 160. Approaches against the interference of autoantibodies with pre-transfusion compatibility testing |
Page:803—808 |
| 161. How to eliminate the interference of warm autoantibodies with antibody identification |
Page:809—812 |
| 162. How autoantibodies interfere with the identification of alloantibodies |
Page:813—817 |
| 163. Elimination of autoantibodies interference with blood group identification and its treatment effect |
Page:818—820 |
| 164. Expression analysis of miRNA profiles in apheresis platelets at the end of storage |
Page:821—827 |
| 165. Molecular characteristics of hepatitis B infection with low level HBsAg and nucleic acid testing non-reactive results in blood donors |
Page:827—831 |
| 166. HLAⅠ-matched transfusion for immune-mediated platelet transfusion refractoriness |
Page:832—835 |
| 167. Establishment and application of digital PCR method for Babesia detection |
Page:835—839 |
| 168. Th9, Th17, Treg Cells and their related cytokines in primary diagnosis of multiple myeloma |
Page:840—843 |
| 169. Influencing factors and timing prediction of hematopoietic stem cell collection in peripheral blood |
Page:843—846 |
| 170. Correlation of DAT-positive hemolytic anemia with gender, age and ABO serological indicators |
Page:847—850 |
| 171. Development of an individualized prediction model of allogenic blood transfusion in elective patients based on machine learning |
Page:850—854 |
| 172. Effect of blood component transfusion in patients with negative to positive results of direct antiglobulin test after blood transfusion |
Page:854—857 |
| 173. Clinical application of washed red blood cells in perioperative patients with liver cancer |
Page:858—860 |
| 174. Detection of antibodies against SARS-CoV-2 as a serologic marker of infection in patients with COVID-19 |
Page:861—864 |
| 175. Clinical value of thromboelastogram in evaluating blood coagulation function for patients with COVID-19 |
Page:864—867 |
| 176. Application of whole blood thromboelastogram and its correlative kit for plasma thromboelastogram detection |
Page:867—870 |
| 177. Reducing the under-reporting rate of adverse transfusion reactions: Application of 5W+ 1H method combined with ECRS analysis principle |
Page:870—873 |
| 178. Correlation between irregular antibody profiles of non-Rh blood group system and incidence of hemolytic disease of the newborn, 53 cases |
Page:874—877 |
| 179. Single-ELISA reactive rate of four blood screening items in 18 blood station laboratories: Henan, 2019 |
Page:878—882 |
| 180. Performance evaluation of HBsAg screening before blood donation in Dalian |
Page:882—885 |
| 181. Analysis of HIV infection among voluntary blood donors in Jinhua, 2013~2020 |
Page:886—888 |
| 182. HCV genotyping of anti-HCV reactive samples by one ELISA assay and blood donor reentry study |
Page:889—891 |
| 183. Characteristics and related factors of adverse reactions to blood donation among medical students |
Page:891—894 |
| 184. Professional values of blood bank staff in Jiangsu Province |
Page:895—899 |
| 185. Free blood use among voluntary blood donors in Shiyan city |
Page:900—903 |
| 186. Clinical analysis of COVID-19 blood recipients: 81 patients |
Page:904—907 |
| 187. Strategies against blood collection and supply during the COVID-19 epidemic, Hainan Province |
Page:907—909 |
| 188. Determination of polymer content in human albumin production process |
Page:909—913 |
| 189. Identification of two novel weak D alleles by sequence-based typing |
Page:913—916 |
| 190. Crossmatch incompatibility caused by CD47 monoclonal antibody therapy:A case report and literature review |
Page:916—918 |
| 191. Anti-N-like antibodies combined with anti-E and anti-c in a chronic hemodialysis patients: A case report |
Page:919—921 |
| 192. Potential of modulating fibrinolytic activity in intervention of transfusion-related acute lung injury |
Page:922—925 |
| 193. Advances in applicaiton of platelets with cold storage at 4℃ and its storage lesion |
Page:926—930 |
| 194. Advances of pathogen inactivation technology in blood components and quality evaluation |
Page:930—935 |
| 195. Research progress of clinical application of human fibrinogen |
Page:935—938 |
| 196. Expert consensus on preparatiopn technique of autologous platelet-rich plasma |
Page:677—683 |
| 197. Discussion on the clinical non-transfusion application of platelet concentrates |
Page:683—684 |
| 198. Observation of therapeutic effect of autologous platelet-rich plasma on joint injury |
Page:685—687 |
| 199. Multivariate analysis of peripheral blood mononuclear cells from children donors |
Page:688—691 |
| 200. Centrifugal plasma separation combined with plasma adsorption in the treatment of hypertriglyceridemia: A clinical observation of 42 cases |
Page:691—694 |
| 201. Autologous platelet-rich plasma(PRP) for treatment of knee arthritis: A comparative study between PRP prepared by manual and automatic plateletapheresis |
Page:695—698 |
| 202. Application of allogeneic platelet gel in surgical operation for giant aortic aneurysms, one case |
Page:698—701 |
| 203. Comparative analysis of miRNA profiles of platelets treated and untreated with riboflavin and ultraviolet-B light |
Page:701—707 |
| 204. Serological and genotyping results of ABO subtypes in tumor patients |
Page:708—712 |
| 205. Micro-determination on activating complement in detecting biological properties of Fc fragment of IVIG |
Page:713—715 |
| 206. Expression of LKB1 gene in bone marrow of patients with acute non-lymphocytic leukemia and its clinical significance |
Page:716—719 |
| 207. Efficacy of "Bushen Huoxue" therapy in patients with transfusion related iron overload in chronic aplastic anemia |
Page:720—724 |
| 208. Correlation analysis of thromboelastogram and routine coagulation test in the detection of cerebrovascular diseases |
Page:724—727 |
| 209. Thromboelastogram parameters and MTHFR gene polymorphism in the diagnosis of adverse fetal pregnancy outcomes |
Page:728—731 |
| 210. Effects of autologous blood transfusion on thrombelastography in patients underwent neurosurgery |
Page:732—735 |
| 211. Platelet antibody positive rate and influencing factors in common related diseases of platelet transfusion: A retrospective study |
Page:735—738 |
| 212. A survey on the availability and convenience of emergency blood transfusion in mainland China |
Page:738—742 |
| 213. Hepatitis B screening of voluntary blood donors and characteristics of HBV positive population, Chongqing |
Page:743—746 |
| 214. Blood inventory changes and blood supply situation during COVID-19 |
Page:747—750 |
| 215. Syphilis infection status among voluntary blood donors in Nanyang area and preventing strategy of blood transfusion transmitted syphilis |
Page:751—754 |
| 216. Motivation, intention and behavior of prenatal blood donation between families of RhD negative and positive pregnant women: A comparative study |
Page:754—758 |
| 217. ARIMA model in blood supply prediction of multi blood components |
Page:759—763 |
| 218. Identification and characterization of Cromer blood group anti-IFC |
Page:764—767 |
| 219. How " blood station-hospital" information management system based on Internet affect blood collection and supply |
Page:767—769 |
| 220. Anti-HCV detection based on laboratory quality index evaluation of blood station |
Page:770—772 |
| 221. Blood donor caring and retention: detail management of plateletpheresis venipuncture |
Page:773—775 |
| 222. Crossmatch incompatibility in infants caused by intravenous immunoglobulin-produced IgG antibody: Six cases |
Page:776—778 |
| 223. Coagulation factor XII deficiency: Clinical report of 7 patients and literature review |
Page:779—781 |
| 224. Investigation and analysis of the status quo of staffing and service provision in blood banks of Zhejiang Province |
Page:781—785 |
| 225. Current information security of blood banks in China |
Page:785—788 |
| 226. Researchprogress of hypoxia-inducible factor-1α in hematological malignancies |
Page:788—792 |
| 227. Epidemiological characteristics of occult hepatitis C virus and safety of blood transfusion |
Page:793—796 |
| 228. Advances in incentives of voluntary blood donation |
Page:797—800 |
| 229. The research of brain glioma therapy for nude mouse using transgenic human umbilical cord mesenchymal stem cells overexpressing TRAIL |
Page:567—573 |
| 230. Efficacy analysis of von Willebrand factor in human coagulation factor FⅧ concentrates in China |
Page:574—578 |
| 231. Study on molecular mechanism and pedigree investigationof para-bombay blood group caused by rare mutations at position h235 and position h649 of FUT1 gene. |
Page:578—580 |
| 232. Analysis of plasma coagulation function in male Tibetan population with different hemoglobin content in Tibet |
Page:581—584 |
| 233. Phenotype screening and gene mutation analysis of platelet CD36 antigen: blood donors in Suzhou area |
Page:585—589 |
| 234. Effect of red blood cell parameters and blood donation interval on ferritin level in apheresis platelet donors with ferritin deficiency |
Page:590—594 |
| 235. Polymorphism analysis of HLA-B alleles in Jiangsu Han population from 8 prefecture-level cities |
Page:595—599 |
| 236. Coagulation functions in a large-dose blood loss/transfusion model by different protocols in vitro |
Page:599—603 |
| 237. Assessing Hemocompatibility of Transfusion Sets for Single Use |
Page:603—606 |
| 238. Two transfusion strategies for severe burn patients in non-shock stage: A comparative study |
Page:607—609 |
| 239. Influence of intravenous immunoglobulin on blood compatibility testing |
Page:610—612 |
| 240. Construction and evaluation of a nomogram prediction model for the efficacy of apheresis platelet transfusion |
Page:613—616 |
| 241. Low-dose rituximab combined with dexamethasone in the treatment of refractory ITP in children: Clinical analysis of 31 cases |
Page:616—619 |
| 242. Thromboelastogram index and postoperative bleeding in patients underwent percutaneous nephrolithotomy |
Page:620—623 |
| 243. Correlation between hemolysis degree and antibody IgG subtypes contained in infant serum and erythrocyte eluates |
Page:624—627 |
| 244. Chidamide monotherapy for the treatment of hepatosplenic T-cell lymphoma: A case report |
Page:628—630 |
| 245. Network public opinion on national blood safety in 2019 |
Page:631—634 |
| 246. ASCVD indexes in Bama and Shimen area plasma donors, China |
Page:634—638 |
| 247. Changing trend in demographic characteristics of voluntary blood donors in Shandong, China |
Page:639—641 |
| 248. Genetic polymorphism and antibody screening of RhD negative Chinese Han population in Jiayuguan |
Page:642—645 |
| 249. Prevention and control strategies of physical examination and health consultation for apheresis donation during the COVID-19 outbreak |
Page:646—649 |
| 250. Performance analysis of light initiated chemiluminescence assay in detecting anti-HCV, anti-HIV and syphilis |
Page:649—652 |
| 251. Quality of cryoprecipitated antihemophilic factor: Impact of storage time following whole blood collection, gender, ABO blood group, age, and preparation method |
Page:652—655 |
| 252. How to improve one-time yield in blood plasma separation |
Page:655—657 |
| 253. Advantages of narrative nursing in blood collection nursing |
Page:657—659 |
| 254. Methods of antibody identification and transfusion strategy for blood matching difficulties caused by anti-E,anti-c, anti-Jka,anti-Wra and anti-Dia |
Page:659—661 |
| 255. Biosafety measures and process optimization for blood transfusion in a tertiary hospital in Wuhan: To respond to the COVID-19 |
Page:662—665 |
| 256. Advances inbiomarkers for immune thrombocytopenia |
Page:665—668 |
| 257. Research progress of red blood cells cultured in vitro |
Page:669—672 |
| 258. Progress in clinical application of umbilical cord blood cells |
Page:673—676 |
| 259. Interference of CD38 monoclonal antibody in blood compatibility testing and its countermeasures: A general consensus among experts |
Page:327—334 |
| 260. Correlation of peripheral myeloid-derived suppressor cells with hepatitis c virus infection |
Page:335—339 |
| 261. Effect of PolyCHb oxygen carrier on partial coagulation indexes in vitro |
Page:339—342 |
| 262. Blood screening strategy for SARS-CoV-2 among low risk populations |
Page:343—346 |
| 263. Effect of sample processing at 56℃ for 30 min on routine examination in Department of Blood Transfusion |
Page:346—349 |
| 264. Genotyping of HPA-1-29bw in platelet donors in Nanjing, China |
Page:349—353 |
| 265. Clinical features and transfusion effectiveness of patients with hematological diseases underwent acute transfusion reactions |
Page:354—358 |
| 266. Efficacy of allogeneic platelet-rich on healing and regeneration of diabetic foot wounds |
Page:358—361 |
| 267. Hemostatic effect of single infusion of tranexamic acid with different loading dose before spinal surgery: a comparative study |
Page:362—365 |
| 268. Clinical effect of blood transfusion inpremature infants with anemia of different severity |
Page:365—368 |
| 269. Serological characteristics and matching strategy of CD38 monoclonal antibody following the treatment of multiple myeloma |
Page:368—370 |
| 270. Unqualified rate of anti-HIV detection in the laboratories from blood banks in Beijing-Tianjin-Hebei region |
Page:371—376 |
| 271. Incidence of adverse reactions to whole blood donation in China: a Meta-analysis |
Page:376—381 |
| 272. Platelet antibody screening and crossmatch in Chengdu in 2019 |
Page:382—385 |
| 273. Investigation on feelings of blood donors during blood donation in Nanjing |
Page:385—388 |
| 274. Daratumomab interference with pre-transfusion examination of patients with multiple myeloma |
Page:389—392 |
| 275. Levofloxacin-induced acute hemolytic anemia: A clinical case report |
Page:392—395 |
| 276. Diagnosis and treatment of hemolytic disease of the newborn caused by red blood cell antibody Fya |
Page:396—399 |
| 277. Effect of psychological counseling nursing in patients receiving advanced autologous apheresis treatment |
Page:399—402 |
| 278. Effect of health publicity on plateletpheresis donation among college students in Beijing |
Page:403—405 |
| 279. Westgard multi-rule control method combined with Levey-Jennings quality control chart in daily indoor quality control of TEG |
Page:405—408 |
| 280. Absorption and elution test and real time PCR in ABO blood group identification: A comparative study |
Page:408—411 |
| 281. Nucleic acid testing results by two different nucleic acid screening systems in blood screening: A comparative study |
Page:411—414 |
| 282. Key performance indexes of two HBsAg ELISA reagents: A retrospectively comparative analysis |
Page:414—417 |
| 283. Premature delivery and severe hemolytic disease of the newborn caused by cold IgG antibody M: A case report |
Page:417—419 |
| 284. Application of intelligent closed-loop mobile nursing management system in quality management of blood transfusion |
Page:420—423 |
| 285. Zika virus infection and transfusion safety |
Page:424—427 |
| 286. Research progress on prognostic factors of primary central nervous system lymphoma |
Page:428—431 |
| 287. Research progress on CAR T-cell neurologic toxicity |
Page:432—434 |
| 288. The distribution characteristics of Rh phenotype and haplotype frequency in Qingdao: An analysis based on some patients and local blood donors |
Page:205—207 |
| 289. Capillary ultracentrifugation technology in accurate identification of Rh phenotype |
Page:208—210 |
| 290. Electronic crossmatching based on Rh typing: reducing the production of Rh system alloantibody in blood transfusion recipients |
Page:210—213 |
| 291. Protective effect of hemoglobin oxygen carrier with different oxygen affinity on isolated rat hearts |
Page:214—218 |
| 292. Hemorheological characteristics and tissue oxygen supply in people with different hemoglobin levels at high altitude |
Page:219—223 |
| 293. Correlation between the polymorphism of erythrocyte membrane blood group glycoprotein A (GPA) related gene GYPA and clonorchis sinensis infection |
Page:223—226 |
| 294. Establishment of kinetic detection method for PKA content |
Page:227—231 |
| 295. Anovel solid-phase agglutination reagent for detecting IgG irregular alloantibodies of red cell blood groups |
Page:232—235 |
| 296. Application of platelet GPⅡb/Ⅲa receptor inhibitor (A adjuvant) in the detection of platelet aggregation function |
Page:236—239 |
| 297. Distribution and haplotype polymorphism of HLA-A、-B、-C、-DRB1、-DQB1 alleles in Anhui Han population |
Page:240—244 |
| 298. Autologous blood transfusion drainage and simple drainage after lumbar surgery: A comparative study |
Page:245—248 |
| 299. Relatedfactors of blood transfusion during total hip arthroplasty |
Page:249—252 |
| 300. Exploring the impact of ABO blood group on the outcomes of allogeneic hematopoietic cell transplantation |
Page:252—256 |
| 301. Blood group serological testings of ABO hemolytic disease of newborn: A retrospective analysis |
Page:256—258 |
| 302. Clinical effect of red blood cells transfusion on newborns with neonatal respiratory distress syndrome |
Page:259—262 |
| 303. Effects of sevoflurane and propofol on coagulation function and postoperative recovery in children with congenital dislocation of hip joint |
Page:262—265 |
| 304. ABO blood group profile of patients in Naqu, Tibet: An analysis from a district-central hospital |
Page:266—270 |
| 305. Current situation of surgical blood ordering and value of optimizing preoperative blood ordering |
Page:270—273 |
| 306. Regional hemovigilance system for adverse reactions to blood donation |
Page:274—277 |
| 307. How reimbursements of blood expenses affect the voluntary blood donation recruitment: A comparative study |
Page:278—280 |
| 308. Service quality evaluation of college students on blood donation: Based on SERVQUAL |
Page:280—283 |
| 309. Recruitment strategy for whole blood donors in Dongguan area: based on demographic characteristics of donors respond to donation appointments |
Page:284—287 |
| 310. IgA removal by plasma component Ⅱ solution: A comparative study of different filter membrane combinations |
Page:287—289 |
| 311. Monoclonal anti-CD47 interference in pre-transfusion test and mitigation measures, a case report |
Page:290—292 |
| 312. HIV screening and confirmation results of voluntary blood donors in Wuhu area |
Page:293—296 |
| 313. HTLV nucleic acid screening platform for blood donors |
Page:296—298 |
| 314. Environmental monitoring in NAT laboratory |
Page:299—302 |
| 315. Cross regional blood donation of a HIV blood donor with missed nucleic acid detection |
Page:303—305 |
| 316. Tn-polyagglutinability of red blood cells and anti-cE antibodies: A case report of identification of a suspicious blood type |
Page:305—308 |
| 317. Primary anti-D immunization by the exposure of DEL red blood cells: A case report |
Page:308—311 |
| 318. Application of Internet of Things in clinical blood management based on RFID technology |
Page:312—315 |
| 319. Real-time monitoring of blood transportation temperature conditions based on Internet of Things technology |
Page:316—318 |
| 320. Emerging andre-emerging infectious pathogens and blood safety |
Page:319—324 |
| 321. Activation of death receptor 3 signaling pathway prevents antibody-mediated transfusion-related acute lung injury via αDR3 antibody |
Page:435—440 |
| 322. Emerging infectious diseases in voluntary blood donors in parts of China: Based on metagenomics analysis |
Page:440—446 |
| 323. Taxonomic classification and detection of potential pathogens in healthy voluntary blood donors: Based on metagenomics analysis |
Page:446—451 |
| 324. Removal oftumor cells from blood by leukocyte filter |
Page:452—455 |
| 325. Efect of PolyCHb on enhancing tissue oxygen supply and the treatment of remvatinib for liver cancer graft: Preliminary observation |
Page:456—460 |
| 326. Correlation between human platelet antigen polymorphisms and platelet parameters |
Page:461—464 |
| 327. Effect of residual sex hormones in sex-differentiated human IgG samples on DC secretion of inflammation-related factors |
Page:465—471 |
| 328. Effect of hsa_circ_0001613 on Zika virus replication: Preliminary study |
Page:472—476 |
| 329. Observation on the role of miR-16-5p in the replication of Zika virus |
Page:477—481 |
| 330. ELISA detection method for IgG, IgM and IgA antibodies against hepatitis E virus: Establishment and preliminary application |
Page:482—485 |
| 331. Frequency analysis of RHD*1227A allele among Rh negative Han population and random population in Liaoning |
Page:486—488 |
| 332. Safety of RhD alloimmunization |
Page:489—493 |
| 333. Clinical analysis of red blood cell transfusion in patients with bone marrow failure |
Page:494—497 |
| 334. Adverse reactions to blood transfusion: A retrospective analysis of 750 cases in Wuxi area from 2017 to 2019 |
Page:498—501 |
| 335. Follow up of hemolytic changes in newborns induced by high titer IgG anti-D |
Page:501—504 |
| 336. Activated coagulation factor Ⅺ(FⅪa)activity in intravenous immunoglobulin preparations from China: An analysis test |
Page:505—509 |
| 337. Fairness of blood bank resources allocation in China |
Page:510—513 |
| 338. Analysis of reasons of insufficient blood collected in Guangzhou during 2018~2020 |
Page:514—516 |
| 339. Age, gender and unqualified blood test of voluntary blood donors in Lianyungang district: A retrospective analysis from 2017 to 2020 |
Page:517—521 |
| 340. Serological and molecular biological analysis of easily missed B311 subtype |
Page:522—525 |
| 341. Stability of two internal control blood nucleic acid detection systems in plateau area |
Page:525—528 |
| 342. HBsAg high S/CO negative samples : A comparative analysis between nucleic acid minipool test and individual test |
Page:528—531 |
| 343. Terminal disinfection effect of hydrogen peroxide atomization sterilizer in blood centers |
Page:532—535 |
| 344. Quality analysis of platelet concentrates prepared with optimized blood collection bags |
Page:535—537 |
| 345. Six Sigma method to improve the efficacy of red blood cell transfusion in patients with stable hemodynamics |
Page:538—540 |
| 346. Para-Bombay phenotype identification and transfusion strategy |
Page:541—543 |
| 347. Investigation and analysis of clinical blood supply in Xi′an |
Page:544—547 |
| 348. Research progress of human intravenous immunoglobulin in the treatment ofCOVID-19 |
Page:547—556 |
| 349. Research progress on thecorrelation between killer cell immunoglobulin-like receptor and tumor |
Page:556—560 |
| 350. Current status of bispecific antibody-mediated immunotherapy for hematologic malignancies |
Page:560—566 |
| 351. Association of HLA-DRB1, -DQB1, -DPB1 alleles and haplotype polymorphisms with acute myeloid leukemia (non-M3) in northern Han population |
Page:101—106 |
| 352. Effects of massive blood transfusion on inflammatory factors, islet B cell function, MODS incidence and mortality in patients with severe traumatic hemorrhage |
Page:107—110 |
| 353. Changes of serum iron and ferritin in regular voluntary blood donors |
Page:111—114 |
| 354. Prevalence of anti- "Mia" in blood donors and patients, Zhongshan city |
Page:114—117 |
| 355. Effect of ABO blood group on coagulation factor Ⅷ activity and fibrinogen content in fresh plasma products |
Page:117—119 |
| 356. Activation, function and metabolismofapheresis platelets during storage |
Page:120—123 |
| 357. Performance evaluation of two chemiluminescence immunoassay reagents for HCV antibody in blood donors screening |
Page:123—127 |
| 358. Validation and evaluation of Roche Cobas S201 system in blood screening for nucleic acid detection and amplification |
Page:128—131 |
| 359. Effect of storage duration of whole blood on the preparation of leukocyte-depleted red blood cells |
Page:132—134 |
| 360. Influencing factors of perioperative red blood cell transfusion in patients underwent lung transplantation |
Page:135—139 |
| 361. Patient blood management: application in complicated adult cardiothoracic surgery |
Page:139—142 |
| 362. Influencing factors of blood use in burn patients during hospitalization: A retrospective analysis |
Page:143—146 |
| 363. Storage duration of suspendedred blood cells affects the efficacy of blood transfusion in patients with aplastic anemia |
Page:146—149 |
| 364. Detection of antibiotic antibodies in 358 patients with anemia: comparative analysis of two methods |
Page:150—153 |
| 365. Centralized blood screening across the regions of Hubei province: a retrospective survey |
Page:154—157 |
| 366. Screening and confirmatory test of HTLV in blood donors, apreliminary study |
Page:158—161 |
| 367. Impact of multiple platelets donation on peripheral blood routine in regular blood donors |
Page:161—164 |
| 368. Blood collection and supply in Tianjin: Statistics and regularity analysis from 2010 to 2019 |
Page:165—168 |
| 369. Recruitment of apheresis platelet donors from the relatives and friends of hospital patients: the demographic analysis |
Page:168—170 |
| 370. Investigation on tension and its influencing factors in blood donation |
Page:171—173 |
| 371. Bood transfusion knowledge among clinical staffs |
Page:174—176 |
| 372. Influencing factors of medical college students′ participation in voluntary blood donation: Logistic regression analysis |
Page:177—179 |
| 373. Causes and preventive measures of lipemic blood in voluntary blood donors |
Page:180—182 |
| 374. The processing of blood with irregular antibodies and its clinical application |
Page:182—185 |
| 375. Blood component quality sampling: the use of characteristic curve scheme |
Page:185—187 |
| 376. Serological and molecular investigation of B (A) blood group and its transfusion strategy: A case report |
Page:188—190 |
| 377. Strategies of blood group typing and blood transfusion for one patient with super-high titer cold anti-I autoantibody |
Page:191—193 |
| 378. Viability of covering clinical blood cost in medical insurance |
Page:193—196 |
| 379. The comparison of the managements and practices of safe administration of blood components between United Kingdom and China Part 5: the introduction of UK policies and procesures to support nurses and midwives making the clinical decision and providing the written instruction for blood transfusion |
Page:197—204 |
